EAM
SYRS

Exome Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Exome Asset Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-298,575
Closed -$642K – 81
2024
Q3 		$642K Buy
298,575
+139,400
+88% +$300K 0.43% 53
2024
Q2 		$821K Buy
+159,175
New +$821K 0.73% 40